Naiyer A. Rizvi

ORCID：0000-0002-1134-7494

发表论文 480 篇 · 总被引 66378 次 · h-index 82

代表论文

• Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer (2023 · Nature Genetics · 被引 198)
• CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (2024 · Nature · 被引 183)
• Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases (2025 · Nature Medicine · 被引 65)
• International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy (2023 · Journal of Thoracic Oncology · 被引 48)
• Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab (2024 · Nature Medicine · 被引 42)
• Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings (2024 · Journal for ImmunoTherapy of Cancer · 被引 11)